PHARM-ASSIST DIRECT LTD

Company number 14849244 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

PHARM-ASSIST DIRECT LTD - Analysis Report

Company Number: 14849244

Analysis Date: 2025-07-29 19:22 UTC

  1. Credit Opinion: DECLINE. The company is newly incorporated (May 2023) and has filed its first set of micro-entity accounts showing net liabilities and a negative net asset position of £97. The absence of meaningful assets or positive working capital and the very limited operational history present a high repayment risk. Additionally, there is no evidence of profitability or cash flow generation to support debt servicing or commercial credit. The sole director is also the sole shareholder, which concentrates control but does not mitigate financial weakness. Given these factors, extending credit at this stage is not advisable without substantial additional security or guarantees.

  2. Financial Strength: The balance sheet as of 31 May 2024 reports total current liabilities of £97 with no reported current assets, resulting in net current liabilities of £97 and net liabilities overall. Shareholders’ funds are negative at £97. The micro-entity status limits detailed disclosures, but the reported figures reflect a minimal financial base and lack of tangible or intangible assets. The company’s financial position is effectively at start-up stage with negligible capitalization and no buffer to absorb operating losses or liquidity shocks.

  3. Cash Flow Assessment: No cash or working capital buffers are evident from the accounts. The negative net current assets indicate the company owes more in short-term liabilities than it holds in assets, a liquidity concern. Absence of cash flow statements limits visibility on operating cash generation, but start-up companies typically experience negative cash flow initially. Without external funding or capital injections, the company’s ability to meet short-term liabilities and fund operations is constrained, increasing the risk of payment delays or default.

  4. Monitoring Points:

  • Quarterly updates on cash flow and working capital position to detect any worsening liquidity.
  • Evidence of operating revenues and profitability trends in future accounting periods.
  • Changes in capital structure or new equity injections to improve net asset position.
  • Director and related party transactions that may affect credit risk.
  • Timely filing of accounts and confirmation statements to maintain transparency and compliance.

Perspective: Business Credit Analyst · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.